Post-placental Intrauterine Device Insertion During Cesarean Section
Hang-up Versus Non-fixation Technique for Immediate Post-placental Intrauterine Device Insertion During Cesarean Section
1 other identifier
interventional
118
1 country
1
Brief Summary
Effective, reversible postpartum contraception decreases the chance of rapid repeat pregnancy and poor perinatal outcome in a subsequent pregnancy especially in women delivered by cesarean section.The traditional 6-week postpartum visits not evidenced based and may not meet patient needs, particularly with respect to provision of contraception.Intrauterine device placement after delivery of the placenta is an appealing strategy for increasing access to postpartum Intrauterine device because it does not require a separate postpartum visit. Advantage of post-placental Intrauterine device insertion, Intrauterine devices are recommended as first-line contraceptives by the American Academy of Pediatricians. The Centers for Disease Control and Prevention united state . Medical Eligibility Criteria for Contraceptive Use places no restrictions on use, and states advantages generally outweigh the risks for immediate postpartum use of Intrauterine devices.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 18, 2018
CompletedFirst Posted
Study publicly available on registry
December 19, 2018
CompletedStudy Start
First participant enrolled
January 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2020
CompletedSeptember 16, 2021
September 1, 2021
1.1 years
December 18, 2018
September 9, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Number of displaced intrauterine device after insertion in both groups
2 weeks
Study Arms (2)
intrauterine device insertion with a suture fixation
ACTIVE COMPARATORIntruterine device through hysterotomy incision during cesarean section with a suture fixation
intrauterine device insertion without a suture fixation
ACTIVE COMPARATORIUD through hysterotomy incision during cesarean section without a suture fixation
Interventions
Post-placental insertion of intrauterine device during Cesarean section
to delivery of the fetus
Eligibility Criteria
You may qualify if:
- Age group : 18-40 years
- Women who will be willing to undergo elective cesarean section
- women desire using Copper IUD as long acting contraceptive method.
You may not qualify if:
- Intrauterine infection.
- Fundal Myoma.
- Hemorrhagic disorder
- Genital tract malignancy
- Uterine atony
- Sexually transmitted infection.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Woman's Health Hospital - Assiut university
Asyut, 71111, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Lecturer
Study Record Dates
First Submitted
December 18, 2018
First Posted
December 19, 2018
Study Start
January 1, 2019
Primary Completion
February 1, 2020
Study Completion
April 1, 2020
Last Updated
September 16, 2021
Record last verified: 2021-09